The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 35, No. 12, pp. 1567-1569. DOI 10.1345/aph.1A110
© 2001 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fisher, A.
Right arrow Articles by Le Couteur, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fisher, A.
Right arrow Articles by Le Couteur, D.

Research Articles

Intracerebral hemorrhage following possible interaction between celecoxib and clopidogrel

AA Fisher and DG Le Couteur

OBJECTIVE: To report a case of intracerebral hemorrhage following short-term, concomitant use of celecoxib and clopidogrel. CASE SUMMARY: An 86-year-old white woman with a medical history of paroxysmal atrial fibrillation, heart failure, osteoarthritis, peptic ulcer disease, chronic airway limitation, and surgery for carcinoma of the bowel and breast began clopidogrel therapy following a syncopal episode. She also began taking celecoxib for osteoarthritis at the same time. Three weeks later, she presented with headaches and left hemiparesis. Computed tomography scan revealed intracerebral hemorrhage that had not been previously detected. Celecoxib and clopidogrel were discontinued, and she recovered fully. DISCUSSION: This is the first case describing a possible interaction between celecoxib and clopidogrel. A pharmacokinetic interaction mediated by CYP2C9 is possible. However, the hemorrhage may have been secondary to the effects of either drug alone or concomitant disease. CONCLUSIONS: Celecoxib and clopidogrel have favorable risk profiles and, therefore, are prescribed widely among older people. However, clinicians should recognize that there may be an interaction between celecoxib and clopidogrel that increases the risk of hemorrhage in older people.


This article has been cited by other articles:


Home page
 J Clin PharmacolHome page
H. Zhou
Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?
J. Clin. Pharmacol., November 1, 2006; 46(11): 1268 - 1289.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. Ernst, R. Eberhardt, M. Wahidi, H. D. Becker, and F. J. F. Herth
Effect of Routine Clopidogrel Use on Bleeding Complications After Transbronchial Biopsy in Humans
Chest, March 1, 2006; 129(3): 734 - 737.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. M. Wahidi, R. Garland, D. Feller-Kopman, F. Herth, H. D. Becker, and A. Ernst
Effect of Clopidogrel With and Without Aspirin on Bleeding Following Transbronchial Lung Biopsy
Chest, March 1, 2005; 127(3): 961 - 964.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 2001 by Harvey Whitney Books Company.